A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Clinical trial NCT06091254 · RECRUITING
Trial details
- NCT number
- NCT06091254
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2028-02-07
- Enrollment
- 822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.